Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Retinoic acid signaling is essential for airway smooth muscle homeostasis
Felicia Chen, … , Ramaswamy Krishnan, Alan Fine
Felicia Chen, … , Ramaswamy Krishnan, Alan Fine
Published August 23, 2018
Citation Information: JCI Insight. 2018;3(16):e120398. https://doi.org/10.1172/jci.insight.120398.
View: Text | PDF
Research Article Pulmonology

Retinoic acid signaling is essential for airway smooth muscle homeostasis

  • Text
  • PDF
Abstract

Airway smooth muscle (ASM) is a dynamic and complex tissue involved in regulation of bronchomotor tone, but the molecular events essential for the maintenance of ASM homeostasis are not well understood. Observational and genome-wide association studies in humans have linked airway function to the nutritional status of vitamin A and its bioactive metabolite retinoic acid (RA). Here, we provide evidence that ongoing RA signaling is critical for the regulation of adult ASM phenotype. By using dietary, pharmacologic, and genetic models in mice and humans, we show that (a) RA signaling is active in adult ASM in the normal lung, (b) RA-deficient ASM cells are hypertrophic, hypercontractile, profibrotic, but not hyperproliferative, (c) TGF-β signaling, known to cause ASM hypertrophy and airway fibrosis in human obstructive lung diseases, is hyperactivated in RA-deficient ASM, (d) pharmacologic and genetic inhibition of the TGF-β activity in ASM prevents the development of the aberrant phenotype induced by RA deficiency, and (e) the consequences of transient RA deficiency in ASM are long-lasting. These results indicate that RA signaling actively maintains adult ASM homeostasis, and disruption of RA signaling leads to aberrant ASM phenotypes similar to those seen in human chronic airway diseases such as asthma.

Authors

Felicia Chen, Fengzhi Shao, Anne Hinds, Sean Yao, Sumati Ram-Mohan, Timothy A. Norman, Ramaswamy Krishnan, Alan Fine

×

Figure 4

TGF-β is activated in RA-deficient ASM.

Options: View larger image (or click on image) Download as PowerPoint
TGF-β is activated in RA-deficient ASM.
(A and B) Immunostaining of phos...
(A and B) Immunostaining of phospho-SMAD2 (p-SMAD2) showing signals within the ASM layer of BMS (B) but not CTR (A) airway, indicating activation of TGF-β signaling in RA-deficient mouse ASM (n = 3 per group). Scale bar: 20 μm. (C) p-SMAD2 to total SMAD2 (tSMAD2) ratio is increased in BMS- and DEAB-treated hASM compared with hASM cultured in CTR medium, indicating higher level of TGF-β activity in the RA-deficient hASM (n = 3). (D) Expression of COL1A2, a transcriptional target of TGF-β signaling, is increased in VAD mASM (compared with VAS mASM) and BMS mASM (compared with CTR mASM) (n = 3 per group). (E) COL1A2 production is increased with BMS- and DEAB-treated hASM compared with CTR hASM (n = 3). Data represent the mean ± SEM. Student’s t test was used to calculate P values in D (*P < 0.05). Two-way ANOVA was used for statistical analysis in C and E where P values were adjusted by Bonferroni’s correction (means with different letters are significantly different with P < 0.05).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts